Skip to main content
Clinical Trials/NCT02678585
NCT02678585
Completed
Not Applicable

Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

Assiut University1 site in 1 country106 target enrollmentDecember 2015

Overview

Phase
Not Applicable
Intervention
Nalbuphine
Conditions
Postoperative Pain
Sponsor
Assiut University
Enrollment
106
Locations
1
Primary Endpoint
Tourniquet and postoperative pain measured by visual analogue scale
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
March 2016
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Bakri

Associate professor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • adult patients
  • American Society of Anesthesiologists (ASA) physical status I-II
  • age between 20 and 50 years old
  • scheduled for elective unilateral short hand surgery

Exclusion Criteria

  • allergy to study medications
  • body mass index \> 35 kg/m2
  • patients with sickle cell disease or Reynaud disease
  • patient refusal

Arms & Interventions

Nalbuphine

53 patients received intravenous regional lidocaine plus Nalbuphine

Intervention: Nalbuphine

Control group

53 patients received intravenous regional lidocaine

Intervention: Lidocaine

Outcomes

Primary Outcomes

Tourniquet and postoperative pain measured by visual analogue scale

Time Frame: 4 hours

Secondary Outcomes

  • Cortisol level(4 hours)

Study Sites (1)

Loading locations...

Similar Trials